WHO Essential Medicines List Ophthalmological Preparations

Size: px
Start display at page:

Download "WHO Essential Medicines List Ophthalmological Preparations"

Transcription

1 WHO Essential Medicines List Ophthalmological Preparations 1. Current data Data from the WHO estimated that there were 161 million people in the world with visual impairment of whom 37 million are blind and 124 million have low vision (WHO, 2004 see references). More than 82% of blind people are over 50 years of age. Approximately 90% of blind people live in developing countries; cataract is the major cause of blindness. 2. Childhood blindness Childhood blindness is a significant problem. There is an estimated 1.4 million blind children below the age of 15 and a further 4.2 million children with visual impairment (WHO, 2004). There is no incidence data on childhood blindness from developing countries (Johnson et al 2003), but it is estimated that approximately 500,000 children become blind each year, the majority of whom live in developing countries. Cataract is known to be one of the leading causes of childhood blindness with an estimated 200,000 children becoming blind with bilateral cataract every year (Foster et al 1997). Congenital abnormalities such as cataract and glaucoma, and external potentially blinding eye diseases, e.g. viral and fungal infections, are more difficult to identify in children than adults. A study in Uganda (Wadell 1998) showed that corneal ulceration was found to be second only to cataract as the main cause of blindness in children. Although the association with fungal keratitis is not confirmed in countries with high humidity (Johnson et al 2003), there is a definite increase in risk of ulceration following trauma with an organic agent (see 4.2). Late presentation of these diseases is a major contributing factor to poor outcome after surgical or medical interventions (Eriksen et al 2006). The pharmaceutical rehabilitation of children is complex and long term. These, and the socio economic conditions associated with children in poverty, demonstrate the need to focus health intervention policies towards this social group. 3. VISION 2020 and WHO Seventy five percent of blindness is estimated to be avoidable. It was to address this that WHO and the International Agency for the Prevention of Blindness established VISION 2020: The Right to Sight, a global initiative for the elimination of avoidable blindness by the year VISION 2020 was launched in February The World Health Assembly has, since then, passed two resolutions on prevention of blindness: WHA56.26 in 2003 and WHA59.25 in The latter urged Member States to make available essential medicines needed for eye care. It is for this reason that the VISION 2020 Technology Working Group, of which Sight Savers International is the Chair, decided to approach WHO with some suggested changes to the ophthalmic section of the WHO Essential Medicines List 1

2 4. Addressing the current needs in eye care through pharmaceutical products. Prevention of blindness is now higher on the global health agenda. In implementing the recommendations of WHA and recognising the advances in ophthalmic practice, it is important that the ophthalmological preparations section of the Essential Medioines List addresses the challenges of modern eye care. This will require changes to the current list. 4.1.Cataract surgery. The surgical methods for correcting cataract blindness in children and adults have changed over time as more sophisticated surgical equipment and techniques have been developed. Advances such as foldable, single piece intraocular lenses, and small incision paediatric and adult cataract surgery, and the related pre and post operative treatments, are not reflected in the current pharmaceuticals listed. Studies and results from the field (Yorston 1998, Lam et al 2001, Mwende et al 2005) have indicated that the visual acuity outcomes from children who have received intraocular (IOL) surgery are encouraging, but immediate and long term pharmaceutical care is, along with other factors, essential to ensure optimal visual potential. The following points are important: To insert an IOL into the eye of a child or adult (Extra Capsule Cataract Extraction and IOL), it is necessary to utilise more instruments and fluids during the surgical procedure. In doing so there is an associated increased risk of infection that was not necessarily as apparent with previous surgical techniques (Intra Capsule Cataract Extraction) (Barry et al 2006). The use of a broad spectrum antibiotic, e.g. Ciprofloxacin, that is effective against gram negative and gram positive bacteria, minimises the potential risk of endophthalmitis occurring from multiple instrumentation and wet or damp hand pieces. The use of small incision surgery assists in reducing the risk of infection but it alone cannot assure that endophthalmitis will not occur The insertion of any prosthesis into the body is associated with a risk of rejection. To address this the use of steroid and antibiotic combination drugs e.g. Betamathasone and Neomycin and/or Gentamycin 0.3% and Dexamethasone 0.1% immediately after surgery will assist in counter acting any likelihood of rejection The intraocular lens is initially inserted into the anterior chamber of the eye. Methycellulose (HPMC) is used as an agent to protect the endothelium while the IOL is rotated and placed into the posterior chamber of the eye. Without its use, especially in the diametrically smaller eyes of children, there could be a much higher incidence of permanent endothelial damage In the event that the posterior capsule is ruptured it is possible to insert an anterior chamber lens. In order to do this the eye is miosed. Pilocarpine 0.5% is the drug of choice. 2

3 4.2. Fungal keratitis. Failure to recognise and treat fungal keratitis can lead to permanent damage to the stromal layer of the cornea and impair corneal clarity. It is rarely a bilateral condition but children and adults can become monocularly blind. If the fungal infection is not adequately treated with effective anti fungal agents, the integrity of the globe is jeopardised. Research has shown that there is a higher incidence of fungal keratitis in developing countries for two reasons. Firstly, children and adults have a higher incidence of traumatic injuries to the eye (Johnson et al 2003), many of which are related to corneal abrasions with vegetable matter as they tend livestock and carry out agricultural work. Secondly, as the ambient temperature increases, countries with high humidity and moist climates, e.g. central and southern Africa and the Indian sub continent, have climates that are conducive to fungal growth. Topical Natamycin 5% is suggested (Johnson et al 2003) as the first line of treatment if fungal keratits is suspected on clinical examination and following corneal scraping. In the developing world fungal keratitis affects the poorest who cannot afford the long term medical treatment for a corneal ulcer. The Essential Medicines List can assist in making the treatment more affordable and widely available to people living in poverty. 5. Accessing essential pharmaceutical medicines in the field The WHO Essential Medicines List is an important tool in making the case for including specific items on national essential pharmaceutical lists. National Pharmaceutical Boards refer to the List as the benchmark for pharmaceutical products that may be exempted from import duty and hence quickly and efficiently passed through custom procedures to the distributing eye units. These factors have an effect on lowering prices and helping to make essential pharmaceuticals affordable to all patients. 6. VISION 2020 Technology Working Group The VISION 2020 Technology Working Group is a sub committee of VISION 2020 with the objective of acting as a focal point for IAPB regarding all matters to do with technology in support of Vision 2020 objectives. The group is responsible for maintaining and updating the Standard List for a Vision 2020 Eye Care Service Unit 2006/7, The objective of the Standard List is to provide guidance on essential medicines, equipment, instruments, optical supplies, and educational resources for delivering effective eye care services in developing countries. The pharmaceuticals suggested for inclusion in the WHO Essential Medicines List are taken from the VISION 2020 Standard List. At the June 2006 meeting of the group the Ophthalmological Preparations section of the WHO Essential Medicines list (March 2005, page 20) was reviewed. It was noted that the section needed revision. These revisions, if in place, could, the Group felt, provide advice for Governments on the pharmaceutical items essential for eye units. A list of drugs was compiled by the Group (Appendix 1), which includes ophthalmic medical advisors, as essential pharmaceuticals to complement the surgical advances in cataract surgery and related post operative treatments required for intraocular lens surgery. Treatments for external viral, fungal, and allergic, and immuno 3

4 suppressed related eye diseases are also needed to supplement the existing list. It is suggested that the medicines in Appendix 1, which are appropriate for adult and paediatric use, should be included in the WHO Essential Medicines List. It has been agreed by all parties that WHO is initially requested to remove IDU from the Ophthalmological Preparations section and substitute with Acylovir Eye Ointment 3% and Acylovir Tablets 200mg. Cochrane Paper (2005, revision 3) indicates that Acylovir over 7 and 14 (Appendix 3) days offers improved healing. 7. Collaboration with the Cochrane Eyes and Vision Group Assistance was sought from the Cochrane Eyes and Vision Group for recent evidence based data to support the recommended revisions to WHO. Unfortunately little up to date data is available (Appendix 2). Assistance would be required for further reviews or updating of existing reviews. Contact person at Cochrane Eyes and Vision Group: Mr R. Wormald MA, MB, MSc, FRCS, FRCOphth International Centre of Eye Health, School of Hygiene and Tropical Medicine, London and Moorfields Eye Hospital, London Conclusion Sight Savers International and the VISION 2020 Technology Working Group request WHO to consider deleting IDU from the Essential Medicines List with immediate effect, and start the process to review the case for inclusion of the medicines in Appendix 1. 4

5 References Barry P., Seal D., Gettinby G., Lees, F., Peterson M., Crawford R., ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study, Journal of Refractive Surgery 32, page Bulletin of the WHO, November 2004, 82 (11). Eriksen J.R., Bronsard A., Mosha M., Carmichael D., Hall A., Courtright P Predictors of Poor Follow up in Children that had Cataract Surgery, Ophthalmic Epidemiology 13, page Foster A., Gibert C., Rahl J Epidemiology of cataract in childhood: a global perspective, Journal of Cataract Refractive Surgery 23, page Johnson G., Minassian D., Weal R. West S., The Epidemiolgoy of Eye Diseases, 2 nd Edition, OU, UK Lam A., Seck C., Gueye N.N., Faye M, Pintart D Cataract surgery with posterior chamber lens implantation in Sengalese children less than 15 yrs old. French Journal of Ophthalmology 24, page Mwende J., Bronsard A., Mosha M, Bowman R., Geneau R., Courtright P Delay in presentation to hospital for surgery for congential and developmental cataract in Tanzania. British Journal of Ophthalmology 89, page Wadell K 1998 Childhood blindness and low vision in Uganda Eye 12. page Yorston D Are intracoular lenses the solution to cataract blindness in Africa? The British Journal of Ophthalmology 82, page

6 APPENDIX 1: SUGGESTED FOR INCLUSION Preparation Anti infective agents Ciprofloxacin Eye Drops 0.3% Anti infective/steroid combination Betamethasone + Neomycin Ointment Gentamycin 0.3% + Dexamethasone Eye Drops 0.1% Miotics Pilocarpine Nitrate Injection 0.5% Anti fungals Use and reasons for inclusion Prevention of postoperative infection. Drug of choice after cataract and glaucoma surgery. In some instances may be used before surgery. Immediate postoperative treatment after cataract & glaucoma surgery Long term treatment of post op inflammation after cataract surgery Used peri operatively to reduce the pupil size in Anterior Chamber Intra Ocular Lens surgery Target group Children and adults Children & adults Children & adults Adults (AC IOL surgery is contra indicated in children) Natamycin 1% Eye Treatment of fungal Children & adults Ointment keratitis Natamycin 5% Suspension As above Children & adults Intraocular Lens Insertion Lubricant Methylcellulose HPMC for intraocular use (viscoelastic) Intraocular Injection for HIV Ganciclovir Injection 500mg per vial Sodium Cromoglycate (cromglicate) Used during Anterior and Posterior Intra Ocular lens cataract. Treatment of CMV retinitis in HIV/AIDS Used for vernal and allergic conjunctivitis Acyclovir eye ointment 3% See Appendix 2 Acyclovir tablets See Appendix 2 Chidren: vital for paediatric surgery & adults Adults (need to check if suitable for children) Especially suitable for children who have recurrent attacks of vernal keratoconjunctivitis. Comments New subcategory New subcategory New subcategory New subcategory ( antiallergic) 6

7 APPENDIX 2: SUMMARY OF EVIDENCE BASE FROM THE COCHRANE EYES AND VISION GROUP Ciprofloxacin Eye Drops Betamethasone + Neomycin Ointment Gentamycin and Dexamethasone eye drops Pilocarpine injection 0.5% Natamycin ointment and suspension Acyclovir ointment and tablets HPMC viscoelastic Intraocular Gangcyclovir Sodium Cromoglycate Perioperative antibiotics for the prevention of acute endophthalmitis following cataract surgery. Lead author: Emily West. Out shortly. Neomycin included in the above review. Non steroidal versus topical steroids for cataract surgery. Lead author: David Goh. Pending. NOTE: Betamethasone may be included, but combination preparations are problematic for reviews because components prevent different problems No specific review but trials may be detected in the above review. NOTE: as above No review at present Medical interventions for Fungal Keratitis. Lead author: Nilo Flor Cruz ll. Pending Interventions for Herpes Simplex Virus Epithelial Keratitis. Review issue , currently being updated. Lead author: Kirk Wilhelmus Viscoelastics for preventing endothelial cell loss in people undergoing cataract surgery. Lead author: Archimedes Agahan. Pending Interventions for CMV retinitis. No lead author currently Title pending on seasonal and perennial conjunctivitis which could also address Sodium Chromoglycate. 7

8 APPENDIX 3: SUGGESTIONS FOR IMMEDIATE DELETION AND SUBSTITUTION Anti infective agent Current Idoxurine 0.1% drops, 0.2% ointment Substitution Antiviral Acyclovir Eye Ointment 3% Acyclovir Tablets 200mg Use and reasons for inclusion Target Group Comments HSV Children and adults Acyclovir has been proved to be a more effective and reliable for long and short term usage New sub category Treatment of herpes simplex keratitis As above Children: have a high recurrence rate of HSV & adults Children : have a high recurrence rate of HSV & adults To replace IDU To replace IDU 8

CORNEAL CONDITIONS CORNEAL TRANSPLANTATION

CORNEAL CONDITIONS CORNEAL TRANSPLANTATION GENERAL INFORMATION CORNEAL CONDITIONS CORNEAL TRANSPLANTATION WHAT ARE CORNEAL CONDITIONS? The cornea is the clear outer layer of the eye. Shaped like a dome, it helps to protect the eye from foreign

More information

Page 1 RED EYES. conjunctivitis keratitis episcleritis / scleritis. Frank Larkin Moorfields Eye Hospital. acute glaucoma anterior uveitis

Page 1 RED EYES. conjunctivitis keratitis episcleritis / scleritis. Frank Larkin Moorfields Eye Hospital. acute glaucoma anterior uveitis The RED EYE and ALLERGIC EYE DISEASE DIAGNOSIS & MANAGEMENT Frank Larkin Moorfields Eye Hospital RED EYES conjunctivitis keratitis episcleritis / scleritis acute glaucoma anterior uveitis post-op. / trauma

More information

Subject Index. Atopic keratoconjunctivitis (AKC) management 16 overview 15

Subject Index. Atopic keratoconjunctivitis (AKC) management 16 overview 15 Subject Index Acanthamoeba keratitis, see Infective keratitis Acute allergic conjunctivitis AKC, see Atopic keratoconjunctivitis Allergy acute allergic conjunctivitis 15 atopic keratoconjunctivitis 15

More information

PAINFUL PAINLESS Contact lens user BOV

PAINFUL PAINLESS Contact lens user BOV Common Causes Allergies Infections Ocular Cornea, uveitis, endophthalmitis Orbital Orbital cellulitis Inflammation Uveitis Scleritis / episcleritis Glaucomas Trauma Foreign bodies Chemical injuries History

More information

Clinical Practice Guide for the Diagnosis, Treatment and Management of Anterior Eye Conditions. April 2018

Clinical Practice Guide for the Diagnosis, Treatment and Management of Anterior Eye Conditions. April 2018 Clinical Practice Guide for the Diagnosis, Treatment and Management of Anterior Eye Conditions This Clinical Practice Guide provides evidence-based information about current best practice in the management

More information

84 Year Old with Rosacea

84 Year Old with Rosacea 84 Year Old with Rosacea S/p tap and injection of intravitreal vancomycin, ceftazidime, dexamethasone Post-injection day#1 Va HM IOP 14 mmhg Post-injection week#3 BCVA 20/20-3 (plano +0.50 x 180) IOP 23

More information

Department of Ophthalmology

Department of Ophthalmology Department of Ophthalmology Period : 02/July/18 to 30/August/18 Semester : 7 th Semester Lecture Lesson Plan Sr. Date Topic Lesson plan Name of Faculty No. 1 02.07.18 Lens- Lens-Anatomy, Classification

More information

OPHTHALMOLOGY REFERRAL GUIDE FOR GPS

OPHTHALMOLOGY REFERRAL GUIDE FOR GPS OPHTHALMOLOGY REFERRAL GUIDE FOR GPS A guidebook to support general practitioners in the management and referral of a range of common eye problems. Contents 3 Introduction 4 Ophthalmic Workup 6 Acute Visual

More information

Condition: Herpes Simplex Keratitis

Condition: Herpes Simplex Keratitis Condition: Herpes Simplex Keratitis Description: Herpes simplex infection is very common but usually remains latent. When the virus is reactivated it travels along the trigeminal nerve to cause local infection

More information

Role of Initial Preoperative Medical Management in Controlling Post-Operative Anterior Uveitis in Patients of Phacomorphic Glaucoma

Role of Initial Preoperative Medical Management in Controlling Post-Operative Anterior Uveitis in Patients of Phacomorphic Glaucoma Original Article Role of Initial Preoperative Medical Management in Controlling Post-Operative Anterior Uveitis in Patients of Phacomorphic Glaucoma Irfan Qayyum Malik, M. Moin, A. Rehman, Mumtaz Hussain

More information

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique Injection Technique Quick-Reference Guide PRECISION PROGRAM Companion booklet for the Video Guide to Injection Technique Available at www.ozurdexprecisionprogram.com Provides step-by-step directions with

More information

Dr. D. Y. Patil Medical College, Pimpri, Pune

Dr. D. Y. Patil Medical College, Pimpri, Pune Dr. D. Y. Patil Medical College, Pimpri, Pune - 411 018 Period : 04/July/16 to 22/September/16 Semester : 7 th Semester Department : Ophthalmology Lecture Lesson Plan Sr No Date Topic Learning objectives

More information

Specialist Referral Service Willows Information Sheets. Cataract surgery

Specialist Referral Service Willows Information Sheets. Cataract surgery Specialist Referral Service Willows Information Sheets Cataract surgery An operating microscope in use A total cataract - the normally black pupil is bluish white Cataract surgery These notes do not cover

More information

Department of Ophthalmology

Department of Ophthalmology Period : 03/July/17 to 07/September/17 Semester : 7 th Semester Department of Ophthalmology Lecture Lesson Plan Sr 1 03.07.17 Uvea-Anatomy, Uvea-Anatomy, Classification of Uveitis Dr R Paranjpe Classification

More information

Ophthalmology. Ophthalmology Services

Ophthalmology. Ophthalmology Services Ophthalmology Ophthalmology Services The Ophthalmology service offers the latest and most comprehensive eye care for patients. With a dedicated team of eye surgeons and consultants, we treat vision problems

More information

Cataract Surgery in Patients with Uveitis

Cataract Surgery in Patients with Uveitis Cataract Surgery in Patients with Uveitis Chris Kalogeropoulos MD, PhD, FEBO Professor of Ophthalmology Faculty of Medicine, University of Ioannina President of Hellenic Society for the Study of Ocular

More information

C ataract is one of the main causes of global blindness

C ataract is one of the main causes of global blindness 1478 EXTENDED REPORT Delay in presentation to hospital for surgery for congenital and developmental cataract in Tanzania J Mwende, A Bronsard, M Mosha, R Bowman, R Geneau, P Courtright... See end of article

More information

MD (Ophthalmology) May 2007 Examination Paper I MD (Ophthalmology) May 2007 Examination Paper II

MD (Ophthalmology) May 2007 Examination Paper I MD (Ophthalmology) May 2007 Examination Paper II All India Institute of Medical Science MD Ophthalmology Time: 3 hours Max. Marks: 100 Attempt all the questions briefly with labeled diagrams wherever possible Q1. Discuss the mechanisms of accommodation

More information

Herpes Zoster Ophtalmicus in a HIV positive patient: A Case Report

Herpes Zoster Ophtalmicus in a HIV positive patient: A Case Report ISPUB.COM The Internet Journal of Neurology Volume 9 Number 2 Herpes Zoster Ophtalmicus in a HIV positive patient: A Case Report G Lopez Bejerano, Y Graza Fernandez Citation G Lopez Bejerano, Y Graza Fernandez..

More information

An Injector s Guide to OZURDEX (dexamethasone intravitreal implant) 0.7 mg

An Injector s Guide to OZURDEX (dexamethasone intravitreal implant) 0.7 mg An Injector s Guide to OZURDEX (dexamethasone intravitreal implant) 0.7 mg This guide is intended to provide injectors with information on the recommended injection technique and the important risks related

More information

A Guide to Administering

A Guide to Administering A Guide to Administering INDICATIONS AND USAGE YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment

More information

Subnormal Vision in Uneventful Cataract Surgery after 6 Weeks Hospital Based Study

Subnormal Vision in Uneventful Cataract Surgery after 6 Weeks Hospital Based Study ISSN 2231-4261 ORIGINAL ARTICLE Subnormal Vision in Uneventful Cataract Surgery after 6 Weeks Hospital Based Study 1* 1 1 V. H. Karambelkar, Ankit Sharma, Viraj Pradhan 1 Department of Ophthalmology, Krishna

More information

DIRECT REFERRAL OF CATARACT PATIENTS COMMUNITY OPTOMETRIST PROTOCOL AND GUIDELINES

DIRECT REFERRAL OF CATARACT PATIENTS COMMUNITY OPTOMETRIST PROTOCOL AND GUIDELINES DIRECT REFERRAL OF CATARACT PATIENTS COMMUNITY OPTOMETRIST PROTOCOL AND GUIDELINES October 2013 Preoperative assessment History Symptoms/social history: is the patient visually affected and do they want

More information

Causes of blindness at Nkhoma Eye Hospital,

Causes of blindness at Nkhoma Eye Hospital, European Journal of Ophthalmology / Vol. 18 no. 6, 2008 / pp. 1002-1006 SHORT COMMUNICATIONS & CASE REPORTS Causes of blindness at Nkhoma Eye Hospital, Malawi J.C. SHERWIN 1, W.H. DEAN 2, N.H. METCALFE

More information

Implantation of a corneal graft keratoprosthesis for severe corneal opacity in wet blinking eyes

Implantation of a corneal graft keratoprosthesis for severe corneal opacity in wet blinking eyes NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Implantation of a corneal graft keratoprosthesis for severe corneal opacity in wet blinking eyes The cornea

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

CORNEAL DENDRITE. What else do you want to know about this patient? What would be your initial treatment?

CORNEAL DENDRITE. What else do you want to know about this patient? What would be your initial treatment? Viral Keratitis CORNEAL DENDRITE What else do you want to know about this patient? What would be your initial treatment? Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes

More information

PREAMBLE TO MSC PAYMENT SCHEDULE: OPTOMETRY SERVICES

PREAMBLE TO MSC PAYMENT SCHEDULE: OPTOMETRY SERVICES PREAMBLE TO MSC PAYMENT SCHEDULE: OPTOMETRY SERVICES A. GENERAL PROVISIONS 1. Eye Examination Benefits Optometric benefits are services defined in Section 23 of the Medical and Health Care Services Regulations,

More information

OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST. David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye.

OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST. David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye. OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye.com A FEW OF THE AREAS WE WILL DISCUSS Red Eye Glaucoma Neuro ophthalmic tid

More information

KPA PFIZER EDUCATION GRANT

KPA PFIZER EDUCATION GRANT KPA PFIZER EDUCATION GRANT What every Paediatrician needs to know in Paediatric Ophthalmology Dr. Njambi Ombaba Paediatricians knowledge in ophthalmology Outline Visual development in a child Amblyopia

More information

INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998

INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVELTYS safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol

More information

GENERAL INFORMATION CORNEAL TRANSPLANTATION

GENERAL INFORMATION CORNEAL TRANSPLANTATION GENERAL INFORMATION CORNEAL TRANSPLANTATION WHAT IS CORNEAL TRANSPLANTATION? A corneal transplant is an operation where a damaged or diseased cornea is replaced with donated, healthy tissue. Also called

More information

Dr Jo-Anne Pon. Dr Sean Every. 8:30-9:25 WS #70: Eye Essentials for GPs 9:35-10:30 WS #80: Eye Essentials for GPs (Repeated)

Dr Jo-Anne Pon. Dr Sean Every. 8:30-9:25 WS #70: Eye Essentials for GPs 9:35-10:30 WS #80: Eye Essentials for GPs (Repeated) Dr Sean Every Ophthalmologist Southern Eye Specialists Christchurch Dr Jo-Anne Pon Ophthalmologist Southern Eye Specialists, Christchurch Hospital, Christchurch 8:30-9:25 WS #70: Eye Essentials for GPs

More information

New Zealand Data Sheet

New Zealand Data Sheet New Zealand Data Sheet Prednisolone-AFT 1% Prednisolone acetate (Ph Eur) 1% w/v ophthalmic suspension Presentation Prednisolone-AFT 1% is a milky white suspension in an eyedropper bottle for ophthalmic

More information

2/26/2017. Sameh Galal. M.D, FRCS Glasgow. Lecturer of Ophthalmology Research Institute of Ophthalmology

2/26/2017. Sameh Galal. M.D, FRCS Glasgow. Lecturer of Ophthalmology Research Institute of Ophthalmology Sameh Galal M.D, FRCS Glasgow Lecturer of Ophthalmology Research Institute of Ophthalmology No financial interest in the subject presented 1 Managing cataracts in children remains a challenge. Treatment

More information

Consent for Cataract Surgery

Consent for Cataract Surgery Consent for Cataract Surgery Introduction This information is given to you so that you can make an informed decision about having an eye operation, before you sign the INFORMED CONSENT DOCUMENT. You have

More information

Optometric Postoperative Cataract Surgery Management

Optometric Postoperative Cataract Surgery Management Financial Disclosures Optometric Postoperative Cataract Surgery Management David Dinh, OD Oak Cliff Eye Clinic Dallas Eye Consultants March 10, 2015 Comanagement Joint cooperation between two or more specialists

More information

Acute Eyes for ED. Enis Kocak. The Alfred Ophthalmology

Acute Eyes for ED. Enis Kocak. The Alfred Ophthalmology Acute Eyes for ED Enis Kocak The Alfred Ophthalmology The problem with eyes Things to cover Ocular anatomy Basic assessment Common presentations Eye first aid and procedures Ophthalmic emergencies What

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Corneal Treatments and Specialized Contact Lenses (Corneal remodeling, Corneal transplant, Corneal collagen crosslinking, Intrastromal Rings- INTACS, Keratoconus treatments,

More information

Secondary Intraocular Lens Implantation in University Hospital l, Kuala Lumpur

Secondary Intraocular Lens Implantation in University Hospital l, Kuala Lumpur Secondary Intraocular Lens Implantation in University Hospital l, Kuala Lumpur Fathilah Jaais, MRCOphth, Department of Ophthalmology, Faculty of Medicine, University of Malaya, Lembah Pantai, 50603 Kuala

More information

INDICATIONS For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye globe.

INDICATIONS For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye globe. Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM PRED FORTE Sterile Eye Suspension COMPOSITION PRED FORTE Sterile Eye Suspension contains: Prednisolone acetate 10 mg/ml Preservative:

More information

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone Package leaflet: information for the user OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone Read all of this leaflet carefully before you are given this medicine because it contains

More information

The visual outcome after implantation of the Multifocal Intra Ocular Lens. Dr.Bhargav Dave National Institute of Ophthalmology Pune

The visual outcome after implantation of the Multifocal Intra Ocular Lens. Dr.Bhargav Dave National Institute of Ophthalmology Pune The visual outcome after implantation of the Multifocal Intra Ocular Lens Dr.Bhargav Dave National Institute of Ophthalmology Pune 1 The era of cataract surgery has come leaps and bounds since the inception

More information

NEW ZEALAND DATA SHEET 1. PRODUCT NAME

NEW ZEALAND DATA SHEET 1. PRODUCT NAME NEW ZEALAND DATA SHEET 1. PRODUCT NAME Flucon fluorometholone 0.1% Eye Drops Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Flucon contains 1.0 mg of fluorometholone (0.1% w/v). Excipient

More information

Uveitis. Pt Info Brochure. Q: What is Uvea?

Uveitis. Pt Info Brochure. Q: What is Uvea? Pt Info Brochure Uveitis Q: What is Uvea? A: Uvea is the middle layer of the eye. It is the most vascular structure of the eye. It provides nutrition to the other parts of the eye. The uvea is made up

More information

Title: Two-photon fluorescence microscopy of corneal riboflavin absorption

Title: Two-photon fluorescence microscopy of corneal riboflavin absorption Title: Two-photon fluorescence microscopy of corneal riboflavin absorption through an intact epithelium. Authors: Daniel M Gore FRCOphth, 1* Paul French PhD, 2 David O Brart MD FRCS, 3 Chris Dunsby PhD,

More information

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM OZURDEX, dexamethasone 700 μg intravitreal implant

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM OZURDEX, dexamethasone 700 μg intravitreal implant Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM, dexamethasone 700 μg intravitreal implant Read all of this leaflet carefully before

More information

Ocular and periocular trauma

Ocular and periocular trauma Ocular and periocular trauma No financial disclosures. Tina Rutar M.D. Assistant Professor of Clinical Ophthalmology and Pediatrics Director, Visual Center for the Child University of California San Francisco

More information

Cataract Surgery Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives

Cataract Surgery Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives NHS Dorset Clinical Commissioning Group Cataract Surgery Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives 1. INTRODUCTION AND SCOPE NHS DORSET CLINICAL COMMISSIONING GROUP

More information

Deep Anterior Lamellar Keratoplasty - Techniques

Deep Anterior Lamellar Keratoplasty - Techniques Deep Anterior Lamellar Keratoplasty - Techniques SHERAZ DAYA MD FACP FACS FRCS(Ed) FRCOphth Financial Disclosure Company Code 1. Abbott Medical Optics Inc. S 2. Bausch + Lomb C,L 3. Carl Zeiss Meditec

More information

AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION

AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION 1 NAME OF THE MEDICINE Fluorometholone acetate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The active ingredient in

More information

OUR EYES & HOW WE SEE

OUR EYES & HOW WE SEE OUR EYES & HOW WE SEE UNDERSTAND MORE ABOUT OUR EYES & HOW WE SEE Our Eyes & How We See The eye is our visual gateway to the world. Within it, an array of delicate components labour away to give us the

More information

10 EYE EMERGENCIES. Who goes, who you better not send! Brant Slomovic, MD, FRCPC University Health Network

10 EYE EMERGENCIES. Who goes, who you better not send! Brant Slomovic, MD, FRCPC University Health Network 10 EYE EMERGENCIES Who goes, who you better not send! Brant Slomovic, MD, FRCPC University Health Network DISCLOSURES I have none PVD CASE 1 WHAT IS A PVD? a process of aging (45-55) liquefaction of vitreous

More information

Innovation In Ophthalmology

Innovation In Ophthalmology Innovation In Ophthalmology INVELTYS TM Approval August 2018 Disclaimers and Notices This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform

More information

CONSENT FOR CATARACT SURGERY REQUEST FOR SURGICAL OPERATION / PROCEDURE AND ANAESTHETIC

CONSENT FOR CATARACT SURGERY REQUEST FOR SURGICAL OPERATION / PROCEDURE AND ANAESTHETIC CONSENT FOR CATARACT SURGERY REQUEST FOR SURGICAL OPERATION / PROCEDURE AND ANAESTHETIC Your doctor has indicated that the condition of your eye appears stable and your cataract surgery and/or implantation

More information

Eye conditions in Samoyeds

Eye conditions in Samoyeds Eye conditions in Samoyeds Information for breeders and pet owners Melbourne EyeVet Mulgrave Essendon Bundoora Frankston Geelong Bendigo Wodonga Traralgon Darwin Extra eyelashes/distichiasis Distichia

More information

Preliminary Programme

Preliminary Programme In conjunction with the Serbian Society of Cataract and Refractive Surgeons 9 11 February 2018 Preliminary Programme General Information Venue Sava Centar, Milentija Popovića 9, Beograd 11070, Serbia Local

More information

Sclerokeratoplasty David S. Chu, M.D. Cases

Sclerokeratoplasty David S. Chu, M.D. Cases Sclerokeratoplasty David S. Chu, M.D. Cases Case 1 40 year-old female from Peru presented to our Service with inflamed OS for 2 months duration. Her symptoms began as red painful OS, which progressively

More information

CATARACT SURGERY IN UVEITIS. Professor Harminder Singh Dua

CATARACT SURGERY IN UVEITIS. Professor Harminder Singh Dua Research Institute of Ophthalmology, Cairo 11 th International Conference, 3-4 February, 2017 CATARACT SURGERY IN UVEITIS Professor Harminder Singh Dua MBBS, DO, DO(Lond), MS, MNAMS, FRCS, FRCOphth., FEBO,

More information

Start with ME. LEAVE A LEGACY OF EXCELLENT OUTCOMES FOR PATIENTS WITH ASTIGMATISM. TECNIS TORIC 1-PIECE IOL

Start with ME. LEAVE A LEGACY OF EXCELLENT OUTCOMES FOR PATIENTS WITH ASTIGMATISM. TECNIS TORIC 1-PIECE IOL LEAVE A LEGACY OF EXCELLENT OUTCOMES FOR PATIENTS WITH ASTIGMATISM. Start with ME. TECNIS TORIC 1-PIECE IOL INDICATIONS: The TECNIS Toric 1-Piece Posterior Chamber Lens is indicated for the visual correction

More information

What are some common conditions that affect the cornea?

What are some common conditions that affect the cornea? What are some common conditions that affect the cornea? Injuries After minor injuries or scratches, the cornea usually heals on its own. Deeper injuries can cause corneal scarring, resulting in a haze

More information

Primary Angle Closure Glaucoma

Primary Angle Closure Glaucoma www.eyesurgeonlondon.co.uk Primary Angle Closure Glaucoma What is Glaucoma? Glaucoma is a condition in which there is damage to the optic nerve. This nerve carries visual signals from the eye to the brain.

More information

Aging & Ophthalmology

Aging & Ophthalmology Aging & Ophthalmology Pr Jean-Marie Rakic Dr Denis Malaise January 2018 Major ocular diseases 1. Cataract 2. Age-related macular degeneration 3. Ischemic optic neuropathy 4. Horton arteritis 5. Glaucoma

More information

FUCH S DYSTROPHY & CATARACT SURGERY TREATMENT ALGORITHM

FUCH S DYSTROPHY & CATARACT SURGERY TREATMENT ALGORITHM FUCH S DYSTROPHY & CATARACT SURGERY TREATMENT ALGORITHM ΙΟΑΝΝΙS Α. MALLIAS, MD, PHD Director of the Dept. of Ophthalmology, Mediterraneo Hospital, Glyfada, Athens, Greece Clinical Fellow in Cornea and

More information

FROM CATARACTS TO CLARITY

FROM CATARACTS TO CLARITY Cathy Cataracts FROM CATARACTS TO CLARITY If you re 55 or older, you may have cataracts and not even know it. What You Need to Know Seeing Beyond the Symptoms Cataracts are one of the leading causes of

More information

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM FML Liquifilm Sterile Eye Suspension COMPOSITION FML Liquifilm Sterile Eye Suspension contains: Fluorometholone 1,0 mg/ml Liquifilm

More information

Dr Rachael Neiderer. Ophthalmologist Auckland. 8:35-8:50 Managing Allergic Conjunctivitis & Why Sodium Chromoglycate is Out

Dr Rachael Neiderer. Ophthalmologist Auckland. 8:35-8:50 Managing Allergic Conjunctivitis & Why Sodium Chromoglycate is Out Dr Rachael Neiderer Ophthalmologist Auckland 8:35-8:50 Managing Allergic Conjunctivitis & Why Sodium Chromoglycate is Out Allergic conjunctivitis Rachael Niederer Greenlane Clinical Centre, Auckland Case

More information

EYE INJURIES OBJECTIVES COMMON EYE EMERGENCIES 7/19/2017 IMPROVE ASSESSMENT OF EYE INJURIES

EYE INJURIES OBJECTIVES COMMON EYE EMERGENCIES 7/19/2017 IMPROVE ASSESSMENT OF EYE INJURIES EYE INJURIES BRITTA ANDERSON D.O. DMC PRIMARY CARE SPORTS MEDICINE ASSOCIATE TEAM PHYSICIAN DETROIT TIGERS OBJECTIVES IMPROVE ASSESSMENT OF EYE INJURIES UNDERSTAND WHAT IS CONSIDERED AN EMERGENCY DEVELOP

More information

NEW ZEALAND DATA SHEET 1. PRODUCT NAME

NEW ZEALAND DATA SHEET 1. PRODUCT NAME NEW ZEALAND DATA SHEET 1. PRODUCT NAME Maxidex TM (dexamethasone) 0.1% sterile ophthalmic suspension and ointment. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Maxidex Ophthalmic Suspension contains

More information

Herpes simplex virus infections of the eye and their management with acyclovir

Herpes simplex virus infections of the eye and their management with acyclovir Journal of Antimicrobial Chemotherapy (1983) 12, Suppl. B, 39-43 Herpes simplex virus infections of the eye and their management with acyclovir M. G. Falcon Eye Department, St Thomas' Hospital, London

More information

Childhood corneal neovascularization

Childhood corneal neovascularization Miltos Balidis PhD, FEBOphth, ICOphth Sotiria Palioura MD,PhD Childhood corneal neovascularization Opacities Cornea clarity is essential for optimal vision at any age. In childhood, loss of corneal transparency

More information

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial Minassian D C, Rosen P, Dart J K, Reidy A, Desai P, Sidhu M Record Status This is a critical

More information

Cataract. What is a Cataract?

Cataract. What is a Cataract? Cataract What is a Cataract? We all have a lens in our eye. This is positioned just behind the iris, which is the coloured ring in the eye that gives your eye its colour. The lens s function is to focus

More information

The Emergent Eye in the Acute Setting

The Emergent Eye in the Acute Setting The Emergent Eye in the Acute Setting Todd P. Margolis MD, PhD Professor of Ophthalmology & Director of the F.I. Proctor Foundation UCSF Physical Exam-- Visual Acuity Essential Corrected visual acuity

More information

Post-LASIK infections

Post-LASIK infections Post-LASIK infections By Mohamed El-moddather Assiss. Prof. and head of department of ophthalmology AL-Azhar unizersity Assuit LASIK has become a common refractive procedure and is generally considered

More information

Results of cataract surgery in young children in east Africa

Results of cataract surgery in young children in east Africa Br J Ophthalmol 2001;85:267 271 267 Kikuyu Hospital, Kenya D Yorston M Wood London School of Hygiene and Tropical Medicine, London, UK A Foster Correspondence to: Dr Allen Foster, London School of Hygiene

More information

UNDERSTAND MORE ABOUT UVEITIS UVEITIS

UNDERSTAND MORE ABOUT UVEITIS UVEITIS UNDERSTAND MORE ABOUT UVEITIS UVEITIS Uveitis What is uveitis? Uveitis is inflammation of the uvea, the middle layer of your eye. The eye is shaped much like a tennis ball, with three different layers

More information

Paediatric acute ophthalmology. Harry Bradshaw

Paediatric acute ophthalmology. Harry Bradshaw Paediatric acute ophthalmology Harry Bradshaw Approach Red eye Leukocoria Neurological Trauma Visual loss Red eye Orbital Eyelid Conjunctiva Cornea Uvea Orbital Orbit fixed volume Contiguous with sinuses,

More information

The cataract laser technology of tomorrow is here for you today. See inside to learn about all your exciting new options

The cataract laser technology of tomorrow is here for you today. See inside to learn about all your exciting new options The cataract laser technology of tomorrow is here for you today. See inside to learn about all your exciting new options What is a cataract? A cataract is a clouding of the lens of the eye. This blocks

More information

Cataract. What is a Cataract?

Cataract. What is a Cataract? Cataract What is a Cataract? We all have a lens in our eye. This is positioned just behind the iris, which is the coloured ring in the eye that gives your eye its colour. The lens function is to focus

More information

PATIENT INFORMATION ON CORNEAL GRAFT

PATIENT INFORMATION ON CORNEAL GRAFT PATIENT INFORMATION ON CORNEAL GRAFT (TRANSPLANT) SURGERY M ANANDAN What is the cornea? The clear window of the eye approximately 0.5mm thick and 12mm across. It lies in front of the fluid filled anterior

More information

Shedding Light on Pediatric Cataracts. Kimberly G. Yen, MD Associate Professor of Ophthalmology Texas Children s Hospital

Shedding Light on Pediatric Cataracts. Kimberly G. Yen, MD Associate Professor of Ophthalmology Texas Children s Hospital Shedding Light on Pediatric Cataracts Kimberly G. Yen, MD Associate Professor of Ophthalmology Texas Children s Hospital A newborn infant presents with bilateral white cataracts. What is the best age to

More information

DALK IN DANGEROUS INFECTIONS

DALK IN DANGEROUS INFECTIONS 32 INTERNATIONAL CONGRESS of the HELLENIC SOCIETY OF INTRAOCULAR IMPLANT AND REFRACTIVE SURGERY CORNEA ROUND TABLE: STROMAL REPAIR DALK IN DANGEROUS INFECTIONS, MD Clinica Degli Occhi Sarnicola, Grosseto

More information

CATARACT & LENS SURGERY CATARACT SURGERY

CATARACT & LENS SURGERY CATARACT SURGERY GENERAL INFORMATION CATARACT & LENS SURGERY CATARACT SURGERY WHAT IS A CATARACT? A cataract is not a growth, but rather a clouding of the normally transparent and flexible lens of the eye. This condition

More information

NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: TABLE OF CONTENTS

NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: TABLE OF CONTENTS NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: 2012-2013 TABLE OF CONTENTS CONDITION PAGE(S) Complete Eye and Vision Examination 2 Vision Screening Procedure

More information

ORIGINAL RESEARCH. Abstract:

ORIGINAL RESEARCH. Abstract: ORIGINAL RESEARCH A study of frequency and etiopathogenesis of corneal blindness at tertiary health care centre Nikose A 1, Sthapak A 2, Ladhdha P 3, Bisen H 4, Kabra A 5, Bisen R 3 Abstract: 1 Associate

More information

Visual Outcome of Traumatic Cataract at Holy Family Hospital, Rawalpindi

Visual Outcome of Traumatic Cataract at Holy Family Hospital, Rawalpindi Original Article Visual Outcome of Traumatic Cataract at Holy Family Hospital, Rawalpindi Muhammad Imran Janjua, Ali Raza, Tariq Shakoor Pak J Ophthalmol 2016, Vol. 32 No. 1.....................................................................................................

More information

Original Article Analysis of corneal injuries in King Mahendra Memorial Eye Hospital Bharatpur, Chitwan

Original Article Analysis of corneal injuries in King Mahendra Memorial Eye Hospital Bharatpur, Chitwan Kathmandu University Medical Journal (2006), Vol. 4, No. 1, Issue 13, 34-39 Original Article Analysis of corneal injuries in King Mahendra Memorial Eye Hospital Bharatpur, Chitwan Adhikari RK Senior Consultant

More information

a.superficial (adenoid layer).contain lymphoid tissue.

a.superficial (adenoid layer).contain lymphoid tissue. Conjunctiva Dr. saifalshamarti Anatomy Microscopic: 1.Epithelium (non keratinized,includes goblet cell). 2.Epithelial basement membrane. 3.Stroma : a.superficial (adenoid layer).contain lymphoid tissue.

More information

Medical Science. Research Paper. 2nd yr post graduate, Dept. Of Ophthalmology, SVS Medical College

Medical Science. Research Paper. 2nd yr post graduate, Dept. Of Ophthalmology, SVS Medical College Dr. A.Narasimha Rao Dr. N.Deepika Dr. D.Chandrakanth Reddy Dr. M. Vijaya Ramaraju ABSTRACT KEYWORDS Research Paper Medical Science Comparative Evaluation of the Anti- Inflammatory Effect of Topical 1 %

More information

CRESP. Cadet Refractive Eye Surgery Program. Phone COL Ava Huchun, M.D.

CRESP. Cadet Refractive Eye Surgery Program. Phone COL Ava Huchun, M.D. CRESP Cadet Refractive Eye Surgery Program Phone 845-938-2207 COL Ava Huchun, M.D. COL Ava Huchun, M.D. University of Hawaii Summa cum laude Creighton Medical School, Magna Cum Laude Madigan Internship

More information

GLAUCOMA SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES

GLAUCOMA SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES Introduction These are summary benchmarks for the Academy s Preferred Practice Pattern (PPP) guidelines. The Preferred Practice Pattern series

More information

THE RED EYE Cynthia McNamara, MD Week 25

THE RED EYE Cynthia McNamara, MD Week 25 THE RED EYE Cynthia McNamara, MD Week 25 Educational Objectives: 1. Know the differential diagnosis and presentation of specific etiologies of the red eye 2. Be able to evaluate patients presenting with

More information

Non Phaco Sutureless Cataract Surgery with Small Scleral Tunnel Incision Using Rigid PMMA IOLS

Non Phaco Sutureless Cataract Surgery with Small Scleral Tunnel Incision Using Rigid PMMA IOLS Original Article Non Phaco Sutureless Cataract Surgery with Small Scleral Tunnel Incision Using Rigid PMMA IOLS Muhammad Hashim Qureshi Pak J Ophthalmol 2007, Vol. 23 No.1.......................................................................................

More information

Guide to modern day cataract surgery

Guide to modern day cataract surgery Guide to modern day cataract surgery What are Cataracts? What are Cataracts? Cataracts are a natural clouding of the lens of the eye. Cataracts form usually because of age, but there are eye injuries and

More information

What you can expect with OZURDEX

What you can expect with OZURDEX Important Information About Noninfectious Uveitis Affecting the Back Segment of the Eye and Treatment What you can expect with OZURDEX Approved Use OZURDEX (dexamethasone intravitreal implant) is a prescription

More information

Role of Intracameral Dexamethasone in Preventing Immediate Postoperative Anterior Uveitis in Paediatric Cataract Extraction

Role of Intracameral Dexamethasone in Preventing Immediate Postoperative Anterior Uveitis in Paediatric Cataract Extraction ORIGINAL ARTICLE Role of Intracameral Dexamethasone in Preventing Immediate Postoperative Anterior Uveitis in Paediatric Cataract Extraction CHAUDARY NASIR AHMAD, ASAD ASLAM KHAN, ZAHID SIDDIQUE, SHAKIL

More information

Relevant and Reliable Systematic Review Mapped to this Section. Relevance of Review to other sections of AAO PPP- 2011

Relevant and Reliable Systematic Review Mapped to this Section. Relevance of Review to other sections of AAO PPP- 2011 Table 1. American Academy for Ophthalmology s (AAO) Preferred Practice Patterns (PPP) Nonsurgical Hodge, 2005 Evid Rep Technol Assess (Summ). 2005 Jul;(117):1-6. Effects of omega- 3 fatty acids on eye

More information

HIDROKORTIZON SA HLORAMFENIKOLOM (10 mg + 2 mg) / ml, eye drops, suspension

HIDROKORTIZON SA HLORAMFENIKOLOM (10 mg + 2 mg) / ml, eye drops, suspension PACKAGE LEAFLET: INFORMATION FOR THE USER HIDROKORTIZON SA HLORAMFENIKOLOM (10 mg + 2 mg) / ml, eye drops, suspension HYDROCORTISONE, CHLORAMPHENICOL This leaflet is a copy of the Summary of Product Characteristics

More information

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM FML-NEO Liquifilm Ophthalmic Suspension COMPOSITION FML-NEO Liquifilm Ophthalmic Suspension contains per ml: Fluorometholone 1,0

More information